Hikma Pharmaceuticals PLC (HIK.L) revealed earnings for its full year that Increases, from the same period last year
The company's earnings totaled $402 million, or $1.81 per share. This compares with $359 million, or $1.61 per share, last year.
Excluding items, Hikma Pharmaceuticals PLC reported adjusted earnings of $503 million or $2.26 per share for the period.
The company's revenue for the period rose 7.1% to $3.34 billion from $3.12 billion last year.
Hikma Pharmaceuticals PLC earnings at a glance (GAAP) :
-Earnings: $402 Mln. vs. $359 Mln. last year.-EPS: $1.81 vs. $1.61 last year.-Revenue: $3.34 Bln vs. $3.12 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.